Delivery Order SPE2DB22D2206-SPE2DB23FGR84
Award Date 4/12/23
Potential Completion Date 5/3/23
Potential Value $108K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading pharmaceutical distribution company. The $160,305.24 delivery order is for the supply of REVLIMID 10 MG CAPSULE 100S to support DLA's medical programs and facilities. No set-aside designation was used for this contract. AmerisourceBergen Drug Corp, as the prime contractor, has an extensive history of...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,556,692,674 units of the pharmaceutical drug REVLIMID 5 mg capsules. The $106,869.32 delivery order was placed on March 25, 2022, with a completion date of April 15, 2022. Amerisourcebergen has an ongoing Indefinite Delivery Contract with the Department of Justice Federal Bureau of Investigation to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $56,490.52 firm-fixed-price contract is for the delivery of Revlimid 10 mg capsules and has an ultimate completion date of January 22, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for $49,926.80. The order is for REVLIMID 10 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of October 9, 2024 and is a firm fixed-price contract. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor. This order is likely part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $227,924.70 firm fixed price contract is for the delivery of REVLIMID 10 MG CAPSULE 100S pharmaceutical products. The contract has an end date of October 14, 2022 and was awarded on September 22, 2022. Amerisourcebergen Drug Corp, through its Corporate Office division, provides pharmaceutical products and services to U.S. government...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide REVLIMID 25 MG CAPSULE 100S. The $107,931.18 award supports DLA Troop Support Medical programs and facilities. AmerisourceBergen Drug Corp, as a prime contractor, has a history of providing pharmaceuticals, medical supplies, and distribution services to government agencies such as the Department of Justice Federal Bureau of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $27,859.78, is for the delivery of REVLIMID 10 MG CAPSULE 28S, a pharmaceutical product, with a performance period through April 3, 2024. This delivery order is issued under an indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp...
- The Defense Logistics Agency awarded a $10,254 firm fixed price delivery order to AmerisourceBergen Drug Corp for REVLIMID 25 mg capsules (21-count units) on December 1, 2025, with completion scheduled for December 22, 2025. This non-set-aside award was issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through December 2026. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $267,465.18 delivery order to AmerisourceBergen Drug Corp for REVLIMID 10 mg capsules (100-count units) under a firm fixed-price contract. The order, issued on May 29, 2025, is scheduled for completion by June 20, 2025, and represents a competitive award with no set-aside designation. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued under...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for 100 units of the 10 mg Revlimid capsule, with a potential value of $158,919.39. The order does not have a set-aside designation. AmerisourceBergen Drug Corp is a prime contractor that provides pharmaceutical products and medical supplies to support DLA's medical and healthcare programs, including for U.S....